WhatsApp used in research, but is this ethical?

By HEOR Staff Writer

March 15, 2023

Globally, WhatsApp Messenger has emerged as one of the world’s fastest-growing MIM applications. It has particularly high penetration rates in India, Indonesia, Malaysia, Brazil and South Africa.

The sub-Saharan African region is characterized by mixed migration flows and multiple health challenges, due to the inequalities experienced in access to healthcare disproportionately affect many groups including migrants and mobile populations. Given the existing structural factors impeding access to healthcare, coupled with high rates of mobile telephone use across the sub-Saharan African region; mobile phones are consistently recognized as having great potential for improving access to healthcare in this context.

WhatsApp was largely used in one of two ways for health research; to send hyperlinks to online surveys, or to deliver and evaluate, either an intervention designed for healthcare users or a communication programme for healthcare providers.

Challenges include efforts taken to ensure privacy, confidentiality and anonymity when using WhatsApp as a data collection tool; significant gender divide in access to mobile phones, with men being far more likely to have access to a device than women; features in WhatsApp that could potentially allow some encrypted messages to be read by unintended recipients, compounding the possible breaches of WhatsApp data.

Reference url

Recent Posts

CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals

By HEOR Staff Writer

December 16, 2025

The CHMP meeting highlights from December 2025 reveal major advancements in drug approvals. What were the key outcomes of the EMA's Committee for Medicinal Products for Human Use session held December 8-11? The committee recommended seven new medicines for approval. These target critical areas li...
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare

By João L. Carapinha

December 15, 2025

Spotlight on Translational Medicine in Portugal Translational medicine Portugal has gained international attention through the EATRIS (European Infrastructure for Translational Medicine) Spotlight program, coordinated by
Arexvy RSV Vaccine Expansion: Broader Access and Impact on Adult Health Outcomes
CHMP Backs Arexvy RSV Vaccine Expansion for All Adults 18+ The Arexvy RSV vaccine expansion has received a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). T...